29 August 2008
Comparison of fluorescent in situ hybridization and histological method for the diagnosis of Helicobacter pylori in gastric biopsy samples
Saeed TajbakhshABCDEFG, Ali Reza Samarbaf-ZadehAFG, Mojtaba MoosavianCFMed Sci Monit 2008; 14(9): BR183-187 :: ID: 867956
Abstract
Background
The establishment of Helicobacter pylori in the stomach and duodenum is associated with gastritis, peptic ulcers, and gastric cancer. Application of suitable methods, including molecular techniques, for an accurate detection of H. pylori can lead to the administration of appropriate drugs and successful therapy. In this study, fluorescent in situ hybridization (FISH) was compared with histology for the diagnosis of H. pylori in gastric biopsy specimens.
Material and Method
Flourescently labeled oligonucleotdie probes that target ribosomal RNA were utilized in the FISH procedure. Ninety-one gastric biopsy specimens were tested by FISH and by histology using hematoxylin-eosin (H-E) and Geimsa stains. Furthermore, clarithromycin resistance in 39 of the 91 specimens was examined by FISH.
Results
The sensitivity and specificity of FISH for the detection of H. pylori were 97.9% and 100%, respectively. Of the 39 samples that were tested for clarithromycin resistance, 19 were FISH positive for H. pylori, of which 15 and 4 specimens were infected with clarithromycin-susceptible and clarithromycin-resistant strains, respectively. There were coccoid forms of H. pylori in a few of the specimens.
Conclusions
FISH is a highly sensitive and specific technique for the diagnosis of H. pylori infection. It can be a method of identification when a patient is infected with coccoid forms of H. pylori. The ability of FISH for determination of clarithromycin resistance is a considerable advantage of this method over histology.
Keywords: In Situ Hybridization, Fluorescence - utilization, Histocytochemistry - methods, Helicobacter pylori - metabolism, Helicobacter Infections - drug therapy, Gastric Mucosa - pathology, Drug Resistance, Bacterial, Sensitivity and Specificity, Clarithromycin - therapeutic use, Biopsy, Anti-Bacterial Agents - therapeutic use
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952